“Therapeutic potential of selective serotonin reuptake inhibitor and anti-inflammatory COX-2 inhibitors drugs for epilepsy” (2022) Research, Society and Development, 11(8), p. e55411831319. doi:10.33448/rsd-v11i8.31319.